Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lister

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2003
High-dose therapy for follicular lymphoma revisited: not if, but when?T Andrew Lister
The New England Journal of Medicine|March 27, 2004
Who should receive myeloablative therapy for lymphoma?T Andrew Lister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Improved survival for patients with follicular lymphomaT Andrew Lister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Treatment of Stage IIIa Hodgkin's disease: long follow-up perspectiveT Andrew Lister
Hematology/Oncology Clinics of North America|August 9, 2005
Secondary central nervous system lymphoma: risk factors and prophylaxisSilvia Montoto, T Andrew Lister
Best Practice & Research. Clinical Haematology|February 8, 2005
The clinical course of follicular lymphomaAma Z S Rohatiner, T Andrew Lister
Methods in Molecular Medicine|July 7, 2005
Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphomaKim Last, Silvana Debarnardi, T Andrew Lister
Hematology. American Society of Hematology. Education Program|November 26, 2002
Central nervous system lymphomaAndrew Lister, Lauren E Abrey, John T Sandlund
British Journal of Haematology|April 3, 2014
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma - response to Meissner et alPaul Greaves, T Andrew Lister, John G Gribben
The Veterinary Record|June 8, 2021
Impact assessment of the reduction or removal of ionophores used for controlling coccidiosis in the UK broiler industryCharles Daniel Parker, Stephen Andrew Lister, Jason Gittins
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2003
High-dose therapy for follicular lymphoma revisited: not if, but when?T Andrew Lister
The New England Journal of Medicine|March 27, 2004
Who should receive myeloablative therapy for lymphoma?T Andrew Lister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Improved survival for patients with follicular lymphomaT Andrew Lister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Treatment of Stage IIIa Hodgkin's disease: long follow-up perspectiveT Andrew Lister
Hematology/Oncology Clinics of North America|August 9, 2005
Secondary central nervous system lymphoma: risk factors and prophylaxisSilvia Montoto, T Andrew Lister
Best Practice & Research. Clinical Haematology|February 8, 2005
The clinical course of follicular lymphomaAma Z S Rohatiner, T Andrew Lister
Methods in Molecular Medicine|July 7, 2005
Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphomaKim Last, Silvana Debarnardi, T Andrew Lister
Hematology. American Society of Hematology. Education Program|November 26, 2002
Central nervous system lymphomaAndrew Lister, Lauren E Abrey, John T Sandlund
British Journal of Haematology|April 3, 2014
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma - response to Meissner et alPaul Greaves, T Andrew Lister, John G Gribben
The Veterinary Record|June 8, 2021
Impact assessment of the reduction or removal of ionophores used for controlling coccidiosis in the UK broiler industryCharles Daniel Parker, Stephen Andrew Lister, Jason Gittins
Pageof 12